卵巢交界性肿瘤患者保留生育功能手术的研究进展  

Advances in Study of Fertility-sparing Surgery in Borderline Ovarian Tumor

作　　者：陈瑞芳[1] 鹿欣[1] 

机构地区：[1]复旦大学附属妇产科医院妇科,上海200011

出　　处：《国际妇产科学杂志》2013年第4期301-304,共4页Journal of International Obstetrics and Gynecology

摘　　要：卵巢交界性肿瘤(BOT)是一类组织学特性和生物学行为介于良、恶性之间的卵巢肿瘤。BOT患者发病年龄较轻,其中约1/3为未生育的年轻患者,而且有年轻化趋势。因此,保留生育功能手术成为近来研究的焦点。大多数BOT患者为Ⅰ期,总体预后良好;而微创技术在妇科的广泛应用也给BOT患者提供了更多手术方式的选择。就BOT保留生育功能手术的预后、妊娠结局,腹腔镜手术在BOT患者中的应用加以综述。Borderline ovarian tumors（BOT） are characterized by histopathologic features and biologic behaviors intermediate between clearly benign and frankly malignant ovarian tumors.They typically present at younger women,one-third of whom have not completed childbearing.Thus,increasing studies have focused on the potential of fertility-preserving surgery in BOT.The majority of BOT diagnosed at stage Ⅰ have an excellent overall prognosis.Moreover,the increased usage of laparoscopic management may provide another choice in surgery procedure for patients with BOT.This review discussed the clinical and fertility outcome of patients with conservative surgery and the application of laparoscopy technology in BOT.

关 键 词：卵巢肿瘤 妇科外科手术 腹腔镜 卵巢交界性肿瘤 保留生育功能手术 

分 类 号：R737.31[医药卫生—肿瘤]